Download presentation
Presentation is loading. Please wait.
Published byBernard Booth Modified over 6 years ago
1
Copyright © 2003 American Medical Association. All rights reserved.
From: Argatroban Anticoagulation in Patients With Heparin-Induced Thrombocytopenia Arch Intern Med. 2003;163(15): doi: /archinte Figure Legend: Time-to-event analysis of the composite end point in the heparin-induced thrombocytopenia study arm for patients treated with argatroban vs controls. Tick marks indicate the days that censoring occurred, with the number of at-risk individuals shown for days 15, 25, and 37. Argatroban therapy was significantly favored (hazard ratio, 0.64; 95% confidence interval, ; P = .02). Date of download: 10/27/2017 Copyright © 2003 American Medical Association. All rights reserved.
2
Copyright © 2003 American Medical Association. All rights reserved.
From: Argatroban Anticoagulation in Patients With Heparin-Induced Thrombocytopenia Arch Intern Med. 2003;163(15): doi: /archinte Figure Legend: Time-to-event analysis of the composite end point in the heparin-induced thrombocytopenia with thrombosis study arm for patients treated with argatroban vs controls. Tick marks indicate the days that censoring occurred, with the number of at-risk individuals shown for days 15, 25, and 37. Argatroban therapy was significantly favored (hazard ratio, 0.56; 95% confidence interval, ; P = .008). Date of download: 10/27/2017 Copyright © 2003 American Medical Association. All rights reserved.
3
Copyright © 2003 American Medical Association. All rights reserved.
From: Argatroban Anticoagulation in Patients With Heparin-Induced Thrombocytopenia Arch Intern Med. 2003;163(15): doi: /archinte Figure Legend: Mean activated partial thromboplastin time (aPTT) responses in patients receiving argatroban. Coefficients of variation at individual times were 21% to 43%. HIT indicates heparin-induced thrombocytopenia; HITTS, HIT with thrombosis. Date of download: 10/27/2017 Copyright © 2003 American Medical Association. All rights reserved.
4
Copyright © 2003 American Medical Association. All rights reserved.
From: Argatroban Anticoagulation in Patients With Heparin-Induced Thrombocytopenia Arch Intern Med. 2003;163(15): doi: /archinte Figure Legend: Mean platelet counts through day 7 for argatroban-treated patients and historical controls. Coefficients of variation at individual times were 53% to 89%. HIT indicates heparin-induced thrombocytopenia; HITTS, HIT with thrombosis. Date of download: 10/27/2017 Copyright © 2003 American Medical Association. All rights reserved.
Similar presentations
© 2025 SlidePlayer.com. Inc.
All rights reserved.